Literature DB >> 10674055

The need for greater involvement of regulatory agencies in assessing adverse drug reactions.

A D Sniderman1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10674055      PMCID： PMC1232272     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Valvular heart disease associated with fenfluramine-phentermine.

Authors:  H M Connolly; J L Crary; M D McGoon; D D Hensrud; B S Edwards; W D Edwards; H V Schaff
Journal:  N Engl J Med       Date:  1997-08-28       Impact factor: 91.245

2.  Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group.

Authors:  L Abenhaim; Y Moride; F Brenot; S Rich; J Benichou; X Kurz; T Higenbottam; C Oakley; E Wouters; M Aubier; G Simonneau; B Bégaud
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

Review 3.  Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen.

Authors:  R L Brent
Journal:  Reprod Toxicol       Date:  1995 Jul-Aug       Impact factor: 3.143

4.  Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.

Authors:  P A Pellikka; A J Tajik; B K Khandheria; J B Seward; J A Callahan; H C Pitot; L K Kvols
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690
  4 in total
  1 in total

1.  Scientific harassment by pharmaceutical companies: time to stop.

Authors:  D Hailey
Journal:  CMAJ       Date:  2000-01-25       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.